Stockreport

Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis [Yahoo! Finance]

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
PDF - EU Marketing Authorization Application (MAA) submission also validated by European Medicines Agency (EMA) BOSTON, July 02, 2024 BUSINESS WIRE Vertex Pharmaceuticals [Read more]